Nephro-Urology Monthly

Published by: Kowsar

Correlation Between Prediabetes Conditions and Microalbuminuria

Adele Bahar 1 , Atieh Makhlough 1 , Atefe Yousefi 1 , Zahra Kashi 1 , * and Saeid Abediankenari 1
Authors Information
1 Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Nephro-Urology Monthly: March 01, 2013, 5 (2); 741-4
  • Published Online: March 30, 2013
  • Article Type: Research Article
  • Received: August 7, 2012
  • Revised: August 31, 2012
  • Accepted: September 11, 2012
  • DOI: 10.5812/numonthly.7646

To Cite: Bahar A, Makhlough A, Yousefi A, Kashi Z, Abediankenari S. Correlation Between Prediabetes Conditions and Microalbuminuria, Nephro-Urol Mon. 2013 ; 5(2):741-4. doi: 10.5812/numonthly.7646.

Abstract
Copyright © 2013, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 2003; 26(3): 868-74[PubMed]
  • 2. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care. 2001; 24(1): 89-94[PubMed]
  • 3. Dell'Omo G, Penno G, Giorgi D, Di Bello V, Mariani M, Pedrinelli R. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis. 2002; 40(1): 1-8[DOI][PubMed]
  • 4. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002; 7(1): 35-43[PubMed]
  • 5. Wang XL, Lu JM, Pan CY, Tian H, Li CL. A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects. Diabet Med. 2005; 22(3): 332-5[DOI][PubMed]
  • 6. Fioretto P, Caramori ML, Mauer M. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia. 2008; 51(8): 1347-55[DOI][PubMed]
  • 7. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984; 310(6): 356-60[DOI][PubMed]
  • 8. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988; 2(8610): 530-3[PubMed]
  • 9. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes. 1996; 45(10): 1289-98[PubMed]
  • 10. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia. 1989; 32(12): 870-6[PubMed]
  • 11. Meigs JB, D'Agostino RB, Sr, Nathan DM, Rifai N, Wilson PW. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care. 2002; 25(6): 977-83[PubMed]
  • 12. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007; 30 Suppl 1-7[DOI][PubMed]
  • 13. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007; 49(2 Suppl 2)-154[DOI][PubMed]
  • 14. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011; 34 Suppl 1-9[DOI][PubMed]
  • 15. Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MCE, Strippoli GFM, et al. on behalf of the IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group: Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: A cross-sectional analytic study. Clin J Am Soc Nephrol. 2007; 2: 984-991
  • 16. Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis. 2004; 44(5): 792-8[PubMed]
  • 17. Tarsio JF, Reger LA, Furcht LT. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association. Diabetes. 1988; 37(5): 532-9[PubMed]
  • 18. Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, Kirch W, et al. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag. 2009; 5(4): 577-85[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments